Equities

Holista CollTech Ltd

Holista CollTech Ltd

Actions
  • Price (USD)0.001
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Oct 27 2023.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Holista CollTech Ltd is a research-driven biotech company. The Company is focused on researching, developing, manufacturing, and marketing health-style products. The Company operates through four segments: Supplements, Ovine Collagen, Infection Control Solutions, and Food Ingredients. The Supplements segment is involved in the manufacture and wholesale distribution of dietary supplements. The Ovine collagen segment is involved in the manufacture and distribution of cosmetic-grade collagen. The Food ingredients segment is involved in the manufacture and wholesale distribution of healthy food ingredients. The Infection control Solutions segment is involved in the infection control solutions. The Company’s products include LOGIC Sweet, Super Bio Silver, OVICOLL, OVINEX, low-GI bread, low-GI noodle and spaghetti, 80Less sugar, Low Fat Chip, and health supplements. The Company's subsidiaries include Holista Biotech Sdn Bhd, Alterni (M) Sdn Bhd, Revonutrix Sdn Bhd, and others.

  • Revenue in AUD (TTM)5.95m
  • Net income in AUD-4.81m
  • Incorporated2000
  • Employees3.00
  • Location
    Holista CollTech Ltd283 Rokeby RdSUBIACO 6008AustraliaAUS
  • Phone+61 86141-3500
  • Fax+61 86141-3599
  • Websitehttps://www.holistaco.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.